172 related articles for article (PubMed ID: 33832101)
1. A five-gene signature for predicting overall survival of esophagus adenocarcinoma.
Lan T; Liu W; Lu Y; Luo H
Medicine (Baltimore); 2021 Apr; 100(14):e25305. PubMed ID: 33832101
[TBL] [Abstract][Full Text] [Related]
2. A glycolysis-related gene signature predicts prognosis of patients with esophageal adenocarcinoma.
Kang H; Wang N; Wang X; Zhang Y; Lin S; Mao G; Liu D; Dang C; Zhou Z
Aging (Albany NY); 2020 Nov; 12(24):25828-25844. PubMed ID: 33234735
[TBL] [Abstract][Full Text] [Related]
3. A six-microRNA signature can better predict overall survival of patients with esophagus adenocarcinoma.
Lan T; Lu Y; Xiao Z; Xu H; He J; Hu Z; Mao W
PeerJ; 2019; 7():e7353. PubMed ID: 31380150
[TBL] [Abstract][Full Text] [Related]
4. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
Xu T; Yuan Y; He C; Yang K
Med Sci Monit; 2021 Jan; 27():e927850. PubMed ID: 33510126
[TBL] [Abstract][Full Text] [Related]
5. Mir-421 and mir-550a-1 are potential prognostic markers in esophageal adenocarcinoma.
Ji Y; Wang L; Chang G; Yan J; Dai L; Ji Z; Liu J; He M; Xu H; Zhang L
Biol Direct; 2023 Feb; 18(1):5. PubMed ID: 36829221
[TBL] [Abstract][Full Text] [Related]
6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
7. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
8. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
9. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
10. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
Hu X; Wu L; Liu B; Chen K
Front Immunol; 2021; 12():651056. PubMed ID: 34122409
[TBL] [Abstract][Full Text] [Related]
11. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a survival model for esophageal adenocarcinoma based on autophagy-associated genes.
Duan L; Cao L; Zhang R; Niu L; Yang W; Feng W; Zhou W; Chen J; Wang X; Li Y; Zhang Y; Liu J; Zhao Q; Fan D; Hong L
Bioengineered; 2021 Dec; 12(1):3434-3454. PubMed ID: 34252349
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
15. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
16. A four-gene signature predicts overall survival of patients with esophageal adenocarcinoma.
Mao Y; Zhang H; He X; Chen J; Xi L; Chen Y; Zeng Y
Transl Cancer Res; 2024 Mar; 13(3):1382-1393. PubMed ID: 38617513
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
19. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
20. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]